Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis

The aim of this work was to evaluate the efficacy and safety of botulinum toxin A (BTX-A) treatment in patients with neurogenic detrusor overactivity. PUBMED, EMBASE, and Cochrane Library were identified on 13 May 2017 to identify relevant randomized controlled trials. All data obtained were analyze...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Renal failure 2019-01, Vol.41 (1), p.937-945
Hauptverfasser:	Wu, Shang-Jun, Xu, Yu-Qiong, Gao, Zheng-Yan, Wang, Zhi-Peng, Zhao, Feng, Liu, Lin, Wang, Sheng
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravesical adverse effects Botulinum toxin botulinum toxin A Botulinum toxin type A Botulinum Toxins, Type A - administration & dosage Botulinum Toxins, Type A - adverse effects Clinical Study Clinical trials Dose-Response Relationship, Drug Humans Injections Meta-analysis Neurogenic detrusor overactivity Placebos - administration & dosage Placebos - adverse effects Randomized Controlled Trials as Topic Severity of Illness Index Treatment Outcome Urinary Bladder - drug effects Urinary Bladder - innervation Urinary Bladder - physiopathology Urinary Bladder, Neurogenic - complications Urinary Bladder, Neurogenic - drug therapy Urinary Bladder, Neurogenic - physiopathology Urinary Bladder, Overactive - complications Urinary Bladder, Overactive - drug therapy Urinary Bladder, Overactive - physiopathology Urinary incontinence Urinary Incontinence - diagnosis Urinary Incontinence - drug therapy Urinary Incontinence - etiology Urinary tract Urinary Tract Infections - chemically induced Urinary Tract Infections - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!